Smoking Cessation Treatment for Head and Neck Cancer Patients
What is the purpose of this trial?
This is a pilot research study examining the use of varenicline (Chantix) and the nicotine patch. The study is designed to find out whether one of these medications is more effective for smoking cessation with head and neck cancer patients. The study has three parts: 1) two intake sessions; 2) an 8-week treatment phase, and 3) a 3-month follow-up.
- 18 Years - N/A
- Yale University
- July 2009
- Last Updated:
- July 12, 2013
- Study HIC#:
Clinicaltrials.gov ID: NCT00931021